Cargando…
Development of Isopropyl-Tailed Chalcones as a New Class of Selective MAO-B Inhibitors for the Treatment of Parkinson’s Disorder
[Image: see text] Thirteen isopropyl chalcones (CA1–CA13) were synthesized and evaluated for their inhibitory activity against monoamine oxidase (MAO). All compounds inhibited MAO-B more effectively than MAO-A. Compound CA4 most potently inhibited MAO-B with an IC(50) value of 0.032 μM, similar to t...
Autores principales: | Kumar, Sunil, Oh, Jong Min, Abdelgawad, Mohamed A., Abourehab, Mohammed A.S., Tengli, Anand Kumar, Singh, Ashutosh Kumar, Ahmad, Iqrar, Patel, Harun, Mathew, Bijo, Kim, Hoon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2023
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9947953/ https://www.ncbi.nlm.nih.gov/pubmed/36844523 http://dx.doi.org/10.1021/acsomega.2c07694 |
Ejemplares similares
-
Introduction of benzyloxy pharmacophore into aryl/heteroaryl chalcone motifs as a new class of monoamine oxidase B inhibitors
por: Sudevan, Sachithra Thazhathuveedu, et al.
Publicado: (2022) -
Trimethoxylated Halogenated Chalcones as Dual Inhibitors of MAO-B and BACE-1 for the Treatment of Neurodegenerative Disorders
por: Koyiparambath, Vishal Payyalot, et al.
Publicado: (2021) -
Piperazine-substituted chalcones: a new class of MAO-B, AChE, and BACE-1 inhibitors for the treatment of neurological disorders
por: Mathew, Bijo, et al.
Publicado: (2021) -
Development of Halogenated-Chalcones Bearing with Dimethoxy Phenyl Head as Monoamine Oxidase-B Inhibitors
por: Rehuman, Nisha Abdul, et al.
Publicado: (2022) -
Development of a Novel Class of Pyridazinone Derivatives as Selective MAO-B Inhibitors
por: Alagöz, Mehmet Abdullah, et al.
Publicado: (2022)